Finance Watch: Biohaven Gains Up To $600m In Fresh Capital

GeoVax, Vaxart BARDA Funding Disrupted

 
• By Mandy Jackson
  
Finance Watch Public Company
• Source: Alamy

More from Finance Watch

More from Scrip